Student Research Paper
Date of Creation
Hyperbaric Oxygen Therapy, or HBOT, is a form of treatment based on the inhalation of 100% pure oxygen while subjected to closed chamber or room at pressures greater than sea level (1 atmosphere, ATA) (Howell et al., 2018; Kocaman, 2020). HBOT is administered through either a mono-place chamber or a multi-place chamber. Mono-place chambers are pressurized with oxygen and are equipped to handle a single person at a time. Multi-place chambers, on the other hand, can accommodate up to 20 people at a time, including medical personnel and intubated patients. These chambers are pressurized with air, and pure oxygen is administered via facemask, hood tent, or endotracheal tube (Gill & Bell, 2004; Howell et al., 2018). Oxygen is primarily used by the body in the formation of ATP, the molecule responsible for fueling cellular processes. When body tissues are injured or damaged, the energetic demand increases, and consequently more oxygen is needed (Kahle & Cooper, 2020). HBOT increases the body’s arterial and tissue oxygen tension, augmenting the amount of oxygen that the blood plasma can carry. This can create a number of beneficial biochemical, cellular, and physiologic effects (Tibbles & Edelsberg, 1996).
This is the author's version of the work. This publication appears in Gettysburg College's institutional repository by permission of the copyright owner for personal use, not for redistribution.
Scheetz, Arden M., "New Developments in Hyperbaric Oxygen Therapy" (2021). Student Publications. 934.